Summary &horbar; Insulin and glucagon levels, the mass of glucose presented to the liver and the portal signal are important regulators of the liver's response to glucose delivery. The portal signal not only serves to direct glucose into the liver but also appears to stimulate its deposition in glycogen. Moreover, the portal signal impacts on tissues other than the liver: intraportal glucose delivery is associated with changes in glucose uptake by nonhepatic tissues and neurally-mediated enhancement of pancreatic insulin secretion. Our current understanding of the neural control of hepatic glucose metabolism includes a tonic block to the entry of glucose into the liver, probably mediated both by sympathetic neural activity and by a low insulin:glucagon ratio. An increase in the portal vein glucose level is detected by sensors in the portal region, which cause a decrease in the firing rate in the afferent fibers in the hepatic branch of the vagus nerve. The change in the afferent firing rate is processed in the hypothalamus and instigates a change in the efferent firing rate in the hepatic and pancreatic branches of the vagus (with corresponding increases in insulin secretion and net hepatic glucose uptake). The 
insulin secretion. Our current understanding of the neural control of hepatic glucose metabolism includes a tonic block to the entry of glucose into the liver, probably mediated both by sympathetic neural activity and by a low insulin:glucagon ratio. An increase in the portal vein glucose level is detected by sensors in the portal region, which cause a decrease in the firing rate in the afferent fibers in the hepatic branch of the vagus nerve. The change in the afferent firing rate is processed in the hypothalamus and instigates a change in the efferent firing rate in the hepatic and pancreatic branches of the vagus (with corresponding increases in insulin secretion and net hepatic glucose uptake). The 41.6 ¡Jmol.kg-1 .min-1 (Abumrad et al, 1982; Bergman et al, 1982; lshida et al, 1983; Barrett et al, 1985; Radziuk, 1987; Moore et al, 1991) . These rates of NHGU were achieved with the pancreatic hormones free to change; arterial plasma glucose concentrations were 7.8 to 10.3 mmol/L (-1.5-to two-fold basal), and arterial plasma insulin concentrations ranged from 300 to 558 pmol/L (-five-to ten-fold basal) (Abumrad et al, 1982; Bergman et al, 1982; Ishida et al, 1983; Barrett et al, 1985; Radziuk, 1987 (Liljenquist et al, 1977; Shulman et al, 1978) . (DeFronzo et al, 1978) . However, several laboratories (Bergman et al, 1982; Ishida et al, 1983; Barrett et al, 1985) demonstrated independently in the conscious dog that NHGU was no different when glucose was administered enterally or infused directly into the portal vein so as to mimic the absorption profile of the enterally-delivered glucose. Although insulin levels and the load of glucose reaching the liver could not be precisely controlled in these studies (Bergman et al, 1982; Ishida et al, 1983; Barrett et al, 1985) , they demonstrated that there was no need to invoke a putative gut factor to explain the enhancement of NHGU with enteral glucose delivery.
Subsequently, investigators in our laboratory (Adkins et al, 1987) (Pagliassotti et ai, 1991 ) .
Further work has been done to compare the time-course of the effect of the portal signal, insulin and the combination of insulin and the portal signal on NHGU . In dogs with fixed, basal levels of glucagon and insulin, hyperglycemia (arterial plasma glucose -13 mM, hepatic glucose load -283 I-Imol.kg-1 .min-1 ) was maintained by peripheral glucose infusion for 90 min. At that point, the dogs were maintained on a glucose infusion which kept the hepatic glucose load -283 I-Imol.kg-1 .min-1 for an additional 240 min.
The animals were divided into four groups for this final 240 min period: one group continued to receive the peripheral glucose infusion with basal insulin (control group), one group received portal glucose with and basal insulin (portal group), one group received a peripheral glucose infusion with insulin at four-fold basal (insulin group) and one group received a portal glucose infusion with insulin at four-fold basal levels (insulin/portal group). The portal and insulin groups demonstrated similar maximal rates of NHGU (-13 and 18 pmol.kg-l .min-1 , respectively). However, the maximal rate was achieved much more rapidly in the portal group than in the insulin group (-15 vs -90 min). The maximal rate of NHGU was highest in the insulin/portal group (23.6 pmol.kg-l .min-1 ), with this rate being achieved within 60 min .
Neural signaling and NHGU Sympathetic and parasympathetic innervation of the liver exerts reciprocal control over hepatic glucose metabolism and glycogen synthesis. Stimulation of the sympathetic innervation, either at the level of the ventromedial hypothalamus (VMH), the subdiaphragmatic splanchnic nerve or the hilus of the liver, increases hepatic glucose and lactate production and raises the blood glucose level (Lautt, 1983; Shimazu, 1987; Niijima, 1989) . VMH stimulation increases the activity of phosphorylase without changing glycogen synthase, and thus reduces the liver glycogen content (Lautt, 1983; Shimazu, 1987; Niijima, 1989) . On the other hand, parasympathetic stimulation at the level of the lateral hypothalamus or the cervical vagus nerve increases hepatic glycogen synthesis and reduces hepatic glucose output (Lautt, 1983; Shimazu, 1987; Niijima, 1989) . LH stimulation is associated with enhanced activity of glycogen synthase, without a change in phosphorylase activity (Lautt, 1983; Shimazu, 1987; Niijima, 1989) . Moreover, the firing rate in the afferent fibers of the hepatic branch of the vagus nerve is inversely proportional to the portal vein glucose concentration (Niijima, 1989) .
Several in vivo studies support a role for the nervous system in regulation of NHGU in response to a glucose load. Atropine infusion to block the parasympathetic nervous system reduced NHGU in response to an enteral glucose load by 44% in conscious dogs (Chap et al, 1985) . In dogs which had undergone complete surgical denervation of the liver, the response to the portal signal was significantly blunted (Adkins-Marshall et al, 1992) , but the rate of NHGU in response to a peripheral glucose infusion was significantly enhanced, compared to that seen in normally innervated dogs (Adkins-Marshall et al, 1992; Moore et al, 1996) . Rates of NHGU during peripheral and portal glucose infusion were similar in the hepatic-denervated dogs, and these rates were intermediate between the rates observed during peripheral and portal glucose infusion in the hepatic-innervated dogs (Adkins-Marshall et al, 1992) . These data are consistent with the existence of a tonic inhibition of NHGU in the postabsorptive state. This inhibition may be produced by sympathetic neural tone, as well as by the hormonal milieu (low levels of circulating insulin and a lower insulin:glucagon ratio than that which prevails following glucose feeding). In response to enteral or portal glucose delivery, the parasympathetic nervous system is activated. The parasympathetic nervous system can enhance NHGU both directly, by stimulating hepatic glucose uptake and glycogen synthesis, and indirectly through stimulation of insulin release (Lautt, 1983; Shimazu, 1987; Niijima, 1989 . In the portal group, glycogen synthase activity and net hepatic glycogen synthesis were significantly increased at 30 min over that in the control group, and net hepatic glycogen synthesis was significantly greater than in the insulin group . At 240 min, hepatic glycogen synthase activity in the insulin group was significantly greater than that in the control and portal groups, and net hepatic glycogen synthesis was significantly greater in both the insulin and portal group dogs than in the control animals. Net hepatic glycogen synthesis in the insulin/portal dogs was significantly higher than in the portal and control group dogs (134 ± 17 7 pmol/g in insulin/portal vs 65 ± 16 in portal and 84 ± 17 7 in insulin) . Thus, the portal signal serves not only to enhance the uptake of glucose by the liver but also to direct a significant portion (-75%) of the glucose into glycogen. The results suggest that insulin and the portal signal act in cooperation with the portal signal stimulating early glycogen accumulation. The effect of the portal signal on glycogen synthase appears to ebb over time, and hyperinsulinemia then assumes a primary role in stimulating glycogen synthase and glycogen accumulation .
EFFECTS OF THE PORTAL SIGNAL ON NONHEPATIC TISSUES
The portal signal affects tissues other than the liver. Both pancreatic insulin output and circulating insulin levels were significantly greater during intraportal glucose infusion than during peripheral glucose infusion, although the glucose infusion rate and the steady-state arterial plasma glucose levels were the same with each delivery route (Dunning et al, 1995) . Autonomic blockade with hexamethonium prevented the enhancement of insulin levels with portal glucose delivery (Dunning et al, 1995) . In addition, the increase in NHGU during intraportal glucose delivery is associated with a decrease in disposition of glucose by nonsplanchnic tissues (Adkins et al, 1987) . These peripheral effects may be neurallymediated; changes in hypothalamic activity are accompanied by changes in glucose uptake in skeletal and cardiac muscle (Takahashi et al, 1992; Lang et al, 1995) . Moreover, hepatic receptors appear to be key elements contributing to the sensations of hunger and satiety. Both the frequency and size of meals are altered in rats in which neural signaling between the liver and central nervous system is interrupted by total hepatic denervation or hepatic vagotomy (Ratto et al, 1991; Yang et al, 1992) . Thus, the portal signal is not an isolated mechanism for regulating hepatic carbohydrate but instead appears to be part of an elaborate system for control of whole body carbohydrate metabolism.
